A company's journey from launch to acquisition is rarely a straight path. It involves overcoming many challenges and obstacles, especially for a pioneering gene therapy company. In this special report, Spark Therapeutics' journey offers some interesting insights into the evolution of a life science business and how it finds an exit.
